ARTICLE | Clinical News
Brabafen regulatory update
January 20, 2014 8:00 AM UTC
Brabant said FDA and the European Commission granted Orphan Drug designation to Brabafen to treat children with severe myoclonic infant epilepsy (Dravet syndrome), a rare and severe form of infantile-...